Investing where it matters most
We view R&D as essential to our growth. That is why we are committed to making a significant investment towards it year after year. Over 13% of our employees are engaged full-time in R&D, and we invested a total amount of €179 million in R&D in 2024.
Decades of innovations
Thanks to our continuous investment in R&D and dedicated specialized teams, we have been at the forefront of decades of landmark discoveries, including the first direct-reading pH/blood gas analyzer and the invention of CO-oximetry, the first fully automated coagulation system, as well as more than 50 biomarkers in the autoimmunity market.
1959
pH/Blood Gas Analyzer
IL 105 – The first direct-reading pH/blood gas analyzer
1967
CO-oximetry
IL182 – Invention of the technique that measures total hemoglobin and oxygenation parameters
2000
GEM® PremierTM 3000
The first multi-test cartridge standardized Acute Care testing platform for all hospital locations
2004
ACL TOP®
The most advanced platform for automated Hemostasis testing
2006
GEM® PremierTM 4000
The only single-component, multi-use cartridge analyzer with integrated CO-oximetry
2008
ACL TOP® 500
The system that delivers Testing Process Automation for mid- to high-volume laboratories
2009
ACL AcuStar®
The first, and only, fully-automated high-sensitivity immunoassay system for Hemostasis testing
2010
Quanta Link®
The easy-to-use workflow management system that gives you immediate control of all your autoimmune IFA, EIA, and chemiluminescence sample processing
2010
Nova View®
The fully automated IFA microscope - combined with an intelligent digital imaging system - that reads and archives images of IFA-stained slides
2011
BIO-FLASH®
The fully automated, random access chemiluminescent platform for high-sensitivity magnetic particle based on immunoassays
2012
ACL TOP® 300 CTS
The system that delivers Testing Process Automation for mid- to high-volume laboratories
2012
Integrated Lab for Autoimmunity
The concept of seamlessly connecting our autoimmunity instruments to the LIS by a centralized data management system
2013
QUANTA Flash®
The immunoassays indicated for semi-quantitative determination of autoantibodies that offer faster response and broader dynamic range than enzyme-based assays for more precise quantification and confidence in result
2015
ACL TOP® Family 50 Series
The breakthrough Hemostasis analyzer with pre-analytical sample check
2016
GEM® PremierTM 5000
The system with Intelligent Quality Management 2 (iQM®2) that enables rapid, quality-assured test results with every sample
2016
QUANTA-Lyser® 4000
The ultra-high throughput IFA processor that reduces hands-on time, safeguards reagent and sample integrity, and accelerates processing speed
2016
GEMweb® Plus 500 Custom Connectivity
The data management system that simplifies operator supervision, provides quality management and full traceability, all from a single interface
2016
HemoHub™ Intelligent Data Manager
The information management solution for Hemostasis laboratories
